Malignant Retroperitoneal Neoplasm — Trials

Malignant Retroperitoneal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

132 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 41
Recruiting: 23
Ph III recruiting: 1
Growth YoY: —
Industry share: 5%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (17)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06753136	Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype	recruiting	N/A	24	Istituto Oncologico Veneto IRCCSOTHER	1	Apr 13, 2026	clinicaltrials
NCT06141369	Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)	recruiting	N/A	21	Shanghai Jiao Tong University School of MedicineOTHER	1	Apr 9, 2026